Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tisporin vs Restasis in Moderate to Severe Dry Eye Disease
NCT01768312Phase 3Completed
- Sponsor
- Hanlim Pharm
- Start
- Aug 2012
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cyclosporine 2% ophthalmic solution in dry eye syndrome (DED), sponsored by Hanlim Pharm. Started Aug 2012; status: completed.
02
Drugs
cyclosporine 2% ophthalmic solution
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT01768312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01768312.